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ABSTRACT 
 
Purpose: A high prevalence of depressive symptomatology has been reported 
amongst sufferers of Obstructive Sleep Apnea (OSA), but it remains unclear as to 
whether this is due to their OSA or other factors associated with the disorder. The 
current study aimed to assess the incidence and aetiology of depression in a 
community sample of individuals presenting to the sleep laboratory for diagnostic 
assessment of OSA.   
Methods: Forty-five consecutive individuals who presented to the sleep laboratory 
were recruited; of those, 34 were diagnosed with OSA and eleven were primary 
snorers with no clinical or laboratory features of OSA. Nineteen control subjects were 
also recruited. Patients and controls completed the Beck Depression Inventory (BDI), 
the Profile of Mood States (POMS), and the Epworth Sleepiness Scale (ESS) to assess 
their mood and sleepiness, prior to their polysomnography.  
Results: All patients reported significantly more depressive symptoms compared to 
healthy controls, regardless of their degree of OSA. There were no significant 
differences between OSA patients and primary snorers on any of the mood and self-
rated sleepiness measures. Depression scores were not significantly associated with 
any of the nocturnal variables. Regression analysis revealed that the POMS fatigue 
subscale explained the majority of the variance in subjects‟ depression scores.  
Conclusions: Fatigue was the primary predictor of the level of depressive symptoms 
in patients who attended the sleep laboratory, regardless of the level of severity of 
sleep-disordered breathing. When considering treatment options, practitioners should 
be aware of the concomitant occurrence of depressive symptoms and fatigue in 
patients presenting with sleep complaints, which may not be due to a sleep disorder. 
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Introduction 
 
Depressive symptoms are commonly reported by patients with Obstructive Sleep 
Apnea (OSA), and higher rates of depressive symptomatology in OSA patients have 
been observed in a number of prevalence studies when compared to the general 
population [1-5]. Between 15% and 56% of OSA patients are diagnosed with a 
depressive disorder [2, 6-8] compared to only 6.6% of the general population[9]. The 
high prevalence of OSA (between 2% and 4% of the adult population [10]) and 
depression in the general population highlights the need for a clearer understanding of 
the association between these two conditions, both of which have a substantial 
economic and social public health burden [11-12]. 
 
Currently, there is conflicting evidence as to the exact relationship between OSA and 
depression [3, 13]. Some studies report an increase in depression score with 
increasing severity of OSA, pointing to the possibility of a causal relationship[3, 14]. 
The generalisability of the findings of these studies are somewhat limited due to their 
focus on patients with severe OSA, and the fact that they have included individuals 
taking antidepressant medication. Conversely, others have found no such relationship 
between disease severity and depressive symptoms in mild to moderate OSA patients 
[13, 15-16], and primary snorers [15]. This suggests that depressive symptoms may 
not be directly associated with nocturnal factors, but may also occur in those with 
milder forms of OSA, and thus other psychosomatic factors may contribute to the 
experience of depression.  
 
Individuals who visit sleep laboratories generally complain of excessive daytime 
somnolence (EDS), fatigue [17-18] and neurocognitive dysfunction [2, 19-21]; 
symptoms which are also hallmarks of depression[22]. A number of Diagnostic and 
Statistical Manual of Mental Disorders, (DSM-IV) criteria for Major Depressive 
Episodes are also features of the OSA sequelae, such as “fatigue” and “a diminished 
ability to think or concentrate” [22]. As such, it is difficult to determine whether a 
causal relationship exists between OSA and depression, or that the association exists 
due to conceptual overlap or a misinterpretation of the concepts of fatigue and 
sleepiness. A number of definitions have been postulated for both. There are distinct 
differences in the aetiology and outcomes of fatigue and sleepiness. Fatigue is a 
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gradual and cumulative process caused by sustained activity, and usually manifests as 
more of a physical state of exhaustion, which overlaps with other constructs, such as 
lethargy, lack of energy, tiredness, decreased strength, and difficulty with 
concentration[17, 23]. Sleepiness, on the other hand, is more often used to describe a 
subjective experience or feeling of difficulty remaining awake, or through objective 
measurement demonstrating increased sleep propensity [24]. The misconception of 
fatigue and sleepiness in patients attending sleep laboratories may contribute to 
measurement errors, and lead to people with depression presenting for evaluation for 
sleep disorders [4]. An indirect association between OSA and depression has been 
observed in previous studies, mediated by daytime sleepiness [13], or fatigue [17-18; 
25], independent of disease severity. It is unknown whether subjective reports of 
sleepiness or fatigue are more responsible for the levels of depression in all patients 
who attend sleep laboratories.  
 
The primary aim of this study was to investigate the degree of depression in a cross-
sectional cohort of consecutive patients who present to the sleep laboratory, with 
different OSA severities compared to a group of healthy controls. This study also 
aimed to determine specific nocturnal and diurnal factors which may contribute to 
depressive symptomatology in these patients  
 
Materials and Methods 
 
 
Forty-five consecutive patients aged between 20 and 69 years (Mean age ± SD = 
49.56 ± 11.95 years) who presented to the sleep laboratory for a diagnostic sleep 
study and who satisfied the inclusion criteria were recruited. All patients had been 
referred to the laboratory for diagnostic assessment of OSA, and underwent an 
overnight polysomnography (PSG; Compumedics S-series, Compumedics Ltd, 
Melbourne Australia). After the PSG, participants were classified into two groups 
based on AASM criteria and previous studies: 1) OSA group (RDI > 5); and 2) 
primary snorers (RDI < 5)[26-27]. Nineteen age-matched controls (Mean ± SD = 
48.11 ± 9.31 years) were also recruited from a similar community population to the 
patient group. Patients and controls were excluded if they had a history of any 
neurological or psychiatric disorders, had a severe or unstable medical condition in 
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the preceding two months, regularly used medication that could adversely affect 
cognitive functioning, or were from a non-English speaking background. Control 
participants were also excluded if they had an Epworth Sleepiness Scale (ESS) score 
greater than 11 [28], or current or previous diagnosis of a sleep disorder, based on an 
overnight PSG and questionnaire.  The study was approved by Swinburne University 
of Technology and Mitcham Private Hospital‟s Human Research Ethics Committees, 
and informed consent was obtained from all participants.  
 
All participants completed a measure of current level of depression and mood prior to 
their diagnostic sleep study. Testing was performed by a trained research assistant. 
The Beck Depression Inventory (BDI-II) is a 21-item self-report inventory for 
assessing current levels of depression [29]. It is based on a series of key aspects of 
behaviour and emotion in which the respondent rates items on a four-point scale (0-3) 
with a potential range of total scores from 0 to 63. The BDI-II has previously been 
utilised to assess levels of depression in OSA patients [3-4, 30-31], and is used in this 
study to provide an empirical measure of the levels of depression in both patient 
groups and controls. The Profile of Mood States (POMS) is a well-established 
measure of mood disorder [32]. The POMS questionnaire consists of a 65-item, five-
point adjective rating scale that reflects six primary mood factors: tension–anxiety, 
depression-dejection, anger-hostility, fatigue-inertia, confusion-bewilderment and 
vigour-activity. The POMS was utilised in this study to identify whether mood state 
differences existed between patients and controls who attended a sleep laboratory, and 
if these profiles were related to nocturnal variables and sleepiness. 
 
All participants underwent full overnight PSG in the sleep laboratory. The following 
measures were included: electroencephalography (EEG), electromyography (EMG) 
and electro-oculography (EOG), nasal-oral thermistor, abdominal and thoracic 
respiratory impedance plethysmography, leg electrodes, and finger pulse oximetry. 
All sleep studies were staged and scored [33] by an experienced sleep scientist 
unaware of the purpose of the study. The respiratory disturbance index (RDI) was 
defined using AASM Chicago criteria as the average number of apneas and 
hypopneas per hour of sleep [27]. A hypopnea was defined as a 50% reduction in 
either the airflow or abdominal and thoracic respiratory effort signals for greater than 
 6 
10 seconds in addition to at least 3% arterial oxygen desaturation. An apnea was 
scored when airflow ceased at the nose and mouth for ≥ 10 seconds [34]. 
Oxyhaemoglobin saturation (SaO
2
) during sleep was recorded using pulse oximetry, 
and the lowest saturation percentage was used for analysis.  
 
Statistical analysis 
 
All data was analysed using Kruskal Wallis Test for non-parametric data to compare 
demographic, mood scores and polysomnography variables between the three groups, 
with Mann-Whitney U test for post hoc comparison. Mann-Whitney U test were also 
used to examine difference in the PLM index between primary snorers and OSA 
patients. Pearson‟s correlations were calculated to assess the relationship between 
nocturnal variables, BMI, mood and sleepiness. Linear regression models were used 
to assess the relative strengths of any significant associations between depression, 
nocturnal variables, mood and sleepiness. 
 
Results 
 
Participant Characteristics  
 
Of the 45 patients who were referred to the sleep laboratory, 34 were diagnosed with 
OSA and eleven were primary snorers (AHI < 5). Subject characteristics and 
nocturnal respiratory results for OSA patients, primary snorers and healthy controls 
are displayed in Table 1. There was no significant difference in age between the three 
groups (P=0.06), however, males were more frequent in the OSA group (χ2 (2) = 7.07, 
P<0.05). Body Mass Index (χ2 (2) = 18.82, P<0.001), RDI (χ2 (2) = 46.04, P<0.001), 
and lowest percentage oxygen saturation (χ2 (2) = 31.49, P<0.001) differed 
significantly between the three groups. Post-hoc tests revealed that both controls and 
primary snorers had a lower BMI, lower RDI, and higher nadir oxygen saturation 
during the night when compared to OSA patients (all P<0.05). There was no 
significant difference in the PLM index (leg movements per hour) between OSA 
patients (Mean = 62.2 ± 52.3) and primary snorers (Mean = 32.2 ± 29.4) (Wilcoxon = 
-1.82; P = 0.69). All leg movements were associated with arousals and also 
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respiratory events, except in two OSA patients and two primary snorers in which leg 
movements were associated with arousals only.   
 
Table 1 Subject characteristics and nocturnal indices of OSA patients, primary snorers and 
healthy controls.   
 
 OSA patients 
Mean (SEM) 
Primary snorers 
Mean (SEM) 
Controls 
Mean (SEM) 
N 34 11 19 
Age 51.44 (2.06) 43.73 (3.10) 48.11 (2.14) 
Sex  (M: F) 
#
 27:7 4:7 12:7 
BMI kg/ m² * 32.36 (0.90) 30.09 (1.90)  25.95 (0.79) 
RDI* 33.89 (4.62) 3.04 (0.65) 2.54 (0.33) 
Arousals/ hour 20.12 (2.65) 11.37 (1.81) 16.54 (1.72) 
SaO2% lowest * 82.79 (1.39) 90.36 (1.02) 92.53 (0.60) 
 
BMI = Body Mass Index (weight (kg)/height (m)²); RDI = respiratory disturbance index; SaO2% 
lowest = lowest arterial oxygen saturation percentage. * Primary snorers and controls (p<0.05) were 
significantly different to OSA patients. 
# 
OSA and primary snorers were significantly different to 
controls.  
 
 
Mood and sleepiness scores 
 
Depression, mood and sleepiness scores for each group are displayed in Table 2.  
There was a significant difference in BDI scores between the groups (χ2 (2) = 9.73, 
P<0.01). Post hoc tests indicated that OSA patients and primary snorers reported 
significantly greater levels of depressive symptoms than controls. On average, OSA 
patients and primary snorers displayed “minimal” depression levels, based on BDI 
normative data [29]. However, over 5% of OSA patients reported “severe” depressive 
symptoms (BDI score > 29), with a further 14.7% indicating “moderate” 
symptomatology (BDI score 20-28). Twenty percent of the primary snorers compared 
with 5% of control subjects displayed „minimal‟ depressive symptoms. Given the 
gender imbalance between groups, it is important to note that no differences in levels 
of depression were evident between sexes (Wilcoxon = -0.49; P = 0.62).  
 
Significant group differences were found for the POMS dimensions tension (χ2 (2) = 
11.50, P<0.005), depression (χ2 (2) = 14.92, P<0.05), anger (χ2 (2) = 16.28, P<0.001) 
and fatigue (χ2 (2) = 10.73, P<0.01). Post hoc tests indicated that both primary snorers 
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and OSA patients reported significantly higher levels of tension, depression, anger 
and fatigue than control subjects. Group differences were also apparent on the ESS (χ2 
(2) = 18.67, P<0.001). Post hoc tests indicated that both primary snorers and OSA 
patients reported significantly greater levels of sleepiness when compared to controls. 
Twenty-one of the 34 (61.8%) OSA patients reported pathological subjective 
sleepiness (ESS >11; [28]).  
 
 
Table 2   Differences in mood and sleepiness scores between the OSA patients, primary 
snorers and healthy controls 
 
Mood Measures OSA patients 
Mean (SD) 
Primary snorers 
Mean (SD) 
Controls 
Mean (SD) 
BDI * 10.44 (8.90) 10.64 (6.30) 4.32 (3.37)  
POMS tension *  10.03 (5.94) 10.45 (7.10) 4.91 (4.32)  
POMS depression *  8.56 (8.82) 10.27 (9.76) 2.42(6.48)  
POMS anger * 7.29 (6.36) 9.27 (8.72) 2.49 (5.11)  
POMS vigor 13.53 (5.87) 13.36 (4.70) 13.19 (6.16) 
POMS fatigue * 13.79 (7.28) 13.45 (9.06) 7.05 (4.63)  
POMS confusion 7.85 (4.92) 8.27 (5.83) 6.25 (3.96) 
ESS * 11.06 (5.47) 9.36 (5.59) 4.58 (2.32)  
 
BDI = Beck Depression Inventory; POMS = Profile of Mood States, ESS = Epworth Sleepiness Scale 
* OSA patients and primary snorers were significantly different compared to controls (p<0.05).   
 
Correlation and regression analyses 
 
Correlational analyses were performed to identify if any significant relationships 
existed between mood scores, nocturnal variables and subjective sleepiness ratings 
(ESS). Sleepiness ratings were significantly associated with the POMS subscales 
tension, depression, anger, fatigue and confusion (Table 3). Similarly, BDI scores 
were significantly correlated with all the POMS sub-scales. Further to this, BDI 
scores were significantly associated with ratings of sleepiness on the ESS. Nocturnal 
variables were not significantly associated with any mood or sleepiness ratings, 
however there was a significant positive association between BMI and depression 
scores (Table 4).   
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Given the identified significant overlap between the measure of depression, 
sleepiness, and mood and the lack of association with the nocturnal variables, the 
sleepiness and mood variables (apart from the depression sub-scale of the POMS due 
to the conceptual overlap) were entered into a hierarchical linear regression analysis 
to ascertain which of these measures best predicted levels of depression. With 
depression scores as the dependant variable and the sleepiness and POMS scores as 
the independent variables, a stepwise regression analysis was conducted. The first 
significant model to emerge from the stepwise regression analysis comprised of the 
fatigue sub-scale of the POMS, which explained 43% of the variance in BDI scores (F 
(1, 63) = 46.83, P<0.001) and the addition of the confusion sub-scale of the POMS 
explained a further 5.5% of the variance (F (2, 63) = 28.73, P<0.001).   
 
Table 3 Correlations between Depression, Mood and Sleepiness 
 BDI  
POMS – Tension 0.62* 
POMS – Depression 0.65* 
POMS – Anxiety 0.44* 
POMS – Vigor -0.43* 
POMS – Fatigue 0.66* 
POMS – Confusion 0.63* 
Epworth Sleepiness Scale 0.38* 
 
BDI = Beck Depression Inventory; POMS = Profile of Mood States; * = p< 0.01 
 
 
Table 4 Correlations between BMI and Nocturnal variables and Subjective Ratings of 
Mood and Sleepiness 
 BMI RDI SaO2% AI 
BDI – Total Score 0.26# 0.13 -0.17 0.13 
POMS – Tension 0.24 0.12 -0.24 -0.01 
POMS – Depression 0.21 0.11 -0.21 -0.13 
POMS – Anxiety 0.18 0.09 -0.13 -0.07 
POMS – Vigor 0.08 0.03 -0.18 -0.14 
POMS – Fatigue 0.21 0.12 -0.22 -0.04 
POMS – Confusion 0.07 -0.03 -0.08 -0.10 
Epworth Sleepiness Scale 0.34* 0.50* -0.48* 0.07 
 
BDI = Beck Depression Inventory; POMS = Profile of Mood States, BMI = Body Mass Index; RDI = 
respiratory disturbance index; SaO2% = lowest arterial oxygen saturation percentage; AI = arousal index. N = 63; 
# = p < 0.05; * = p< 0.01 
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Discussion 
 
This study prospectively investigated the incidence of depression in a group of OSA 
patients, primary snorers and controls, and examined the possible factors which 
contribute to this depressive symptomatology. The two major findings of this study 
were firstly that all patients attending the sleep laboratory, regardless of their OSA 
diagnosis, reported significantly higher fatigue, daytime sleepiness and depressive 
symptomatology when compared to a healthy control group. Secondly, the level of 
fatigue reported by these patients was the primary contributor to their depressive 
symptoms.  
 
Of the OSA patients, over 20% reported moderate to severe depression, which is 
consistent with other reports of between 7% and 58% of OSA patients with significant 
depressive ratings [6, 13, 35]. Interestingly, a proportion of the primary snorers in the 
current study also reported moderate to severe depressive symptomatology, whilst no 
control subjects reported these levels of depression. This indicates that depression 
may be present in people attending the sleep laboratory, regardless of the degree of 
OSA severity.  
 
Findings from the correlational analyses failed to show any significant association 
between nocturnal OSA variables (RDI, arousal index, lowest SaO2%) and depressive 
symptomatology, consistent with previous studies [13, 15, 17, 25]. However, BMI 
was significantly associated with depression scores, in line with previous reports. 
Regression analysis revealed that the degree of depressive symptoms was predicted by 
levels of fatigue and confusion. This study was the first to assess nocturnal variables, 
subjective sleepiness ratings, mood and depression scores in OSA patients and 
primary snorers, compare these scores to a control group, and determine that fatigue 
was the strongest predictor of depression. 
 
The separate impact of sleepiness and fatigue on depressive symptoms in OSA has 
been examined previously [13, 25]. The current study included both a measure of 
fatigue and sleepiness into the regression model to determine which factor predicted 
the most variance in depressive scores. The fatigue symptoms reported by patients 
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largely accounted for the depressive symptoms, regardless of disease severity, 
explaining nearly half the variance in depression scores. Similarly, Bardwell et al. 
(2003) found that depressive symptoms accounted for approximately 40% of the 
variance in fatigue reported in OSA patients after apnoea severity was taken into 
account [25]. In addition to these findings, levels of both depressive symptoms and 
fatigue have been found to be attenuated by CPAP treatment [36-37], further 
supporting the existence of an interaction between these symptoms within sleep 
disturbed populations.  
 
OSA patients and primary snorers did not differ significantly in daytime somnolence 
and mood, despite differences in nocturnal indices. This raises the possibility that 
there may be some other underlying cause for the hypersomnolence experienced by 
primary snorers presenting for clinical assessment. The PLM index was not 
significantly different between the patient groups, although there was a trend to a 
higher PLM index in the OSA group. The PLM index is similar to that reported in 
other OSA populations [38]. In most cases, these leg movements were associated with 
arousals and respiratory events, thus we do not believe that these patients had a 
diagnosis of PLM disorder. Two of the OSA patients and two primary snorers had 
PLMs associated with arousals only that may have contributed to daytime 
somnolence. Patients with a high arousal index and low RDI in the presence of 
significant snoring have previously been described as having Upper Airway 
Resistance Syndrome [39], which could contribute to sleepiness.  
 
Limitations 
There are a number of limitations of the current study which should be addressed. The 
findings of the current study are limited by the severity of OSA patients used. Patients 
with a greater severity of OSA may have greater functional impairment and report 
higher daytime sleepiness than the patients used in the current study. Significant 
differences between primary snorers and control subjects on depression and mood 
scores were observed, but given the small group sizes, and the inherent referral bias of 
recruiting at sleep clinics [5], this finding should be interpreted with caution.  
 
It has been noted previously that women tend to be under diagnosed for OSA, due to 
atypical symptoms [40]. Further, there is a greater incidence of depression amongst 
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females in the general population [41]. Although no differences were observed in 
levels of depression between males and females in the current study, these findings 
should be interpreted with caution due to the greater number of females in the primary 
snorers group.  
 
Another possible confounder affecting the relationship between OSA and depression, 
which may also interact with gender, is obesity [3, 5]. Indeed a significant association 
between BMI and depression scores emerged in the current study, however this did 
not influence the relationship between fatigue and depression in a separate analysis. 
Future studies should attempt to control for the possible confound of obesity when 
examining the relationship between OSA, depression and fatigue.  
 
Conclusion 
Taken together, the findings that primary snorers and mild OSA patients have similar 
levels of depressive symptoms, which are primarily driven by reported levels of 
fatigue rather than nocturnal factors, have important clinical implications. Utilisation 
of clinical scales of fatigue and depression, in addition to excessive daytime 
sleepiness, should be included in the clinical interview for patients presenting to sleep 
physicians. Depressive symptoms may also impact upon compliance of treatment for 
OSA, such as CPAP or weight loss. In situations where a patient does report high 
levels of depression and or fatigue, it would be important to closely monitor the 
effectiveness of treatment in reversing not only the physiological signs of sleep apnea, 
but also the daytime sequale. These findings also have important clinical implications 
for physicians reviewing patients with depression who may have a concomitant sleep 
disorder. Difficulties with sleep could exacerbate depressive symptoms, and 
potentially affect the efficacy of pharmaceutical treatment.   
 
Although the underlying mechanisms of these mood changes in individuals attending 
the sleep laboratory is still unknown, we have shown for the first time that fatigue is a 
significant contributor to the depressive symptoms reported  by primary snorers and 
OSA patients alike. Whether fatigue is a causal factor leading to greater depression in 
these patients is yet to be determined. Future studies need to include a broader range 
of measures designed to assess daytime functioning of patients attending sleep 
laboratories, and examine the attenuation of depression and mood disturbances with 
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treatment. This would be an interesting and useful area of research which would aid 
understanding of the nature of the psychological changes associated with sleep 
disturbance, and would assist practitioners in diagnosis and treatment across different 
severities of OSA.   
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